Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
6.03
-0.15 (-2.43%)
Dec 1, 2025, 12:43 PM EST - Market open
Cybin Market Cap
Cybin has a market cap or net worth of $300.92 million as of December 1, 2025. Its market cap has increased by 28.59% in one year.
Market Cap
300.92M
Enterprise Value
253.54M
1-Year Change
28.59%
Ranking
Category
Stock Price
$6.03
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $300.92M, an increase of 230.33%. That is a compound annual growth rate of 26.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 308.40M | 74.82% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |